K

Active Director Director DIN 09714319
DIN 09714319 First appointment Aug 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Aug 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Kailash

Data last updated:

Kailash is a Director at Medgiant Pharmaceuticals Private Limited (since 2024) and Director at Glemic Global Solution Private Limited (since 2022). The companies operate in Pharma and Chemicals.

DIN 09714319
Primary Designation Director
Industry Pharma
First Appointment 24 Aug 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Feb 20242024Active
Director24 Aug 20222022Active

Board colleagues of Kailash

Directorship timeline

Open interactive timeline →
Glemic Global Solution Private Limited
Medgiant Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kailash

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kailash

Kailash currently holds 2 directorships: Medgiant Pharmaceuticals Private Limited (Director, since 05 Feb 2024); Glemic Global Solution Private Limited (Director, since 24 Aug 2022).

Kailash was first appointed on 24 Aug 2022 as Director at Glemic Global Solution Private Limited. The most recent appointment on record is 05 Feb 2024 at Medgiant Pharmaceuticals Private Limited.

The current boards of Kailash's companies include Saiful Molla (Medgiant Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available